Report Overview

The Telemedicine market in the EU is estimated to grow from USD 9.9B in 2019 to over USD XX in 2028, with a CAGR of XX%

Telemedicine or telehealth has emerged as an essential component of healthcare during the current COVID-19 crisis. The countries in the EU have accelerated the adoption of digital health. As per the study published by Paris Region Institute in April 2020, France has seen a major surge in teleconsultation from 10,000 teleconsultations per week before confinement to more than a million the last week of April, a multiplication by 100. This is the major factor that is propelling the growth of the market. In 2018, according to the GLOBOCAN report, cancer affected more than 12 million people in the EU. To leverage the potential opportunities, the players in the market are coming with technological innovations and product launches as the growth driver for their company as well for the market in this region. For instance, in August 2020, a new digital health company, named HealthHero, was launched in the focused EU market



Market Growth Drivers

The significant factors contributing to the growth of the EU Telemedicine market are high literacy rate, rise in population of elderly patients, better socio-economic conditions, increase in adoption of IT solutions in healthcare, rise in demand for basic care services, the emergence of favorable policies and advancements in telecommunications. Also, rising healthcare expenditure, increasing preference for remote patient monitoring couple with the rising burden of chronic diseases are the factors propelling the growth in this region